How do you take berberine?
| Product | Strength | Label schedule |
|---|---|---|
| Integrative Therapeutics capsule1 | 500 mg berberine HCl per capsule | Adults: 1 capsule two to three times daily, or as recommended by a healthcare professional |
| Indiana Botanic Gardens vege capsule3 | 500 mg berberine HCl dihydrate per capsule | 1 vege capsule twice daily after a meal, or as directed by a qualified health care professional |
| Integrative Therapeutics berberine complex capsule4 | Barberry root extract 400 mg, Oregon grape root and stem extract 400 mg and goldenseal root and rhizome extract 100 mg per 2-capsule serving, so not berberine alone | Adults: 2 capsules three times daily, or as recommended by a healthcare professional |
What strengths and schedules do berberine labels give?
The table is set at the top of the page
These are dietary supplement maker labels: searches of DailyMed and NCCIH found no approved label or regulator dose for berberine. Berberine is sold as capsules and tablets; searches turned up no powder with mixing directions. A strength can be given as a salt: in a crossover of twelve healthy volunteers (Petrangolini, 2021), a 500 mg berberine chloride tablet was equivalent to 452 mg berberine.5
What did human trials use per dose and per day?
| Trial | Dose and schedule | People | Length |
|---|---|---|---|
| Diabetes pilot, study A (Yin, 2008)2 | 500 mg three times daily at the beginning of each major meal, against metformin 500 mg three times daily after major meals | 36 adults with newly diagnosed type 2 diabetes, 18 on berberine | 13 weeks |
| Diabetes pilot, study B (Yin, 2008)2 | 500 mg three times daily added to previous treatment | 48 adults with poorly controlled type 2 diabetes | 3 months |
| MASLD trial (Lei, 2026)6 | 0.5 g berberine hydrochloride twice daily (1 g/d), against placebo, with lifestyle interventions in both arms | 337 diabetes-free individuals with obesity and MASLD, 169 on berberine and 168 on placebo | 6 months after a 30-day run-in on 0.5 g twice daily |
| BRIEF-SIBO protocol (Guo, 2023)7 | 400 mg twice a day (800 mg daily), against rifaximin 400 mg twice a day | 180 patients with SIBO planned, no results saved | 2 weeks, with follow-up to 6 weeks |
| CYP crossover (Guo)8 | 300 mg three times daily (8 am, 4 pm, 11 pm), against placebo, with a 4-week washout | Eighteen healthy Chinese men entered, 17 completed | 14 days |
In the diabetes pilot (Yin, 2008), 14 (24.1%) patients had berberine cut from 0.5 g to 0.3 g three times daily because of gastrointestinal adverse events.2 The MASLD authors chose 1.0 g a day to optimise tolerability and adherence.6 Searches found no completed human trial of berberine alone for SIBO; the BRIEF-SIBO authors say there is little evidence on it as a single agent.7
A 2021 meta-analysis (Guo, 2021) of 4,158 participants, adults with type 2 diabetes or prediabetes in trials of 4 weeks to 6 months, found that berberine seemed to achieve better effects on glucose levels at 1.5–2 g daily in patients under 60; low-dose berberine (< 1 g/d) achieved promising effects on fasting glucose, and low and medium doses (1–2 g) showed the same effects on HbA1c and 2hPG.9 Sources differ on dose: the MASLD authors cite a 3-arm trial of 184 patients with MASLD and impaired glucose regulation or type 2 diabetes, where berberine at 1.5 g daily for 16 weeks, against lifestyle intervention alone, reduced liver fat; they note its higher baseline metabolic risk.6
When and for how long did trials give it?
Study A of the diabetes pilot (Yin, 2008) gave doses at the beginning of each major meal, and the CYP crossover (Guo) at 8 am, 4 pm and 11 pm.28 The completed trials in the table gave berberine daily for a stated period (14 days in the CYP crossover, 6 months in the MASLD trial), the BRIEF-SIBO protocol plans 2 weeks, and none of the sources states a berberine on/off cycle.867
How do labels say to store berberine?
The Indiana Botanic Gardens capsule label says to store in a dry, cool place.3 Both Integrative Therapeutics labels say to keep the container tightly closed, store at room temperature and avoid excessive heat and direct sunlight.14 Searches found no other storage statement and no stability data after opening.
Frequently asked questions
How is berberine given, and how well is it absorbed?
The labels and trials give it by mouth; no other route turned up. In a placebo-controlled crossover pilot of five men (Moon, 2022), plasma berberine AUC was higher after 100 mg dihydroberberine (284.4 ng/mL × 120 min) than after 500 mg berberine (42.3 ng/mL × 120 min).10
Does berberine affect other medicines?
In a placebo-controlled crossover of eighteen healthy Chinese men, 17 of whom completed it (Guo), 300 mg three times daily for 14 days decreased CYP2D6, 2C9 and 3A4 activities, and the authors flag drug-drug interactions.8 The Integrative Therapeutics capsule label warns about pregnancy or nursing and says to consult a healthcare professional first if diabetes or prescription drugs apply.1
References
- NIH DSLD product label. LZP10711_01_Berberine_60ct_FNL.indd. api.ods.od.nih.gov
- PubMed Central. Efficacy of Berberine in Patients with Type 2 Diabetes. 2008. pmc.ncbi.nlm.nih.gov
- NIH DSLD product label. GMO BLOOD SUGAR AND. api.ods.od.nih.gov
- NIH DSLD product label. LZP78169_C01_Berberine_90ct_FNL.indd. api.ods.od.nih.gov
- PubMed Central. Development of an Innovative Berberine Food-Grade Formulation with an Ameliorated Absorption: In Vitro Evidence Confirmed by Healthy Human Volunteers Pharmacokinetic Study. 2021. pmc.ncbi.nlm.nih.gov
- PubMed Central. Berberine and Adiposity in Diabetes-Free Individuals With Obesity and MASLD. 2026. pmc.ncbi.nlm.nih.gov
- PubMed Central. Berberine and rifaximin effects on small intestinal bacterial overgrowth: Study protocol for an investigator-initiated, double-arm, open-label, randomized clinical trial (BRIEF-SIBO study). 2023. pmc.ncbi.nlm.nih.gov
- PubMed Central. Repeated administration of berberine inhibits cytochromes P450 in humans. 2011. pmc.ncbi.nlm.nih.gov
- PubMed Central. The Effect of Berberine on Metabolic Profiles in Type 2 Diabetic Patients: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. 2021. pmc.ncbi.nlm.nih.gov
- PubMed Central. Absorption Kinetics of Berberine and Dihydroberberine and Their Impact on Glycemia: A Randomized, Controlled, Crossover Pilot Trial. 2021. pmc.ncbi.nlm.nih.gov